OHE Publications

OHE releases a number of publications throughout the year, authored by OHE team members and/or outside experts. All are free for download as pdf files; hard copies of some publications are available upon request.

A description of the OHE publications categories.


von Grebmer, K.

April 1978

It has not normally been OHE policy to reprint articles which have previously been published elsewhere. However, it seemed desirable to make an exception for this paper by Dr Klaus von Grebmer which has been published in two parts in German in Die Pharmazeutische Industrie. This is because it is a useful compilation of many arguments relating to pharmaceutical pricing, which deserves to be available in the English language as well as in German.

Laing, W.

Series on Health
April 1978

The incidence of treatable chronic renal failure in Britain and other Western countries is very small indeed. The most commonly quoted figure is forty people (under sixty years old) per million total population per year.1 Compared with conditions like coronary heart disease, cancer, bronchitis or arthritis, therefore, the magnitude of renal failure as a current health problem appears insignificant.

Series on Health
November 1977

Britain's one and a half million physically handicapped people do not form a homogeneous group. It is wrong to regard them as a discrete section of the population with identical difficulties and interests; for just as the basic abilities, learnt skills and other personal characteristics of 'normal' people vary very widely so too do those of persons who happen to have a disabling condition.

September 1977

The information which pharmaceutical manufacturers provide for prescribing doctors – in the form of sales promotion and advertising – has been the subject of considerable and sometimes acrimonious controversy in Britain since the early 1960s. One result of this has been persistent political pressure to restrict both the content and volume of this information under the National Health Service. In response, the pharmaceutical manufacturers have accepted that in this respect they have to operate in a politically delicate environment.

Series on Health
April 1977

In 1808 Charles Badham adopted the term 'bronchitis' to define collectively 'chronic pectoral (chest) complaints, especially those of people advanced in life . . . ' This definition is of relevance today in that it serves to illustrate the wide range of morbid states that bronchitis may encompass and hence the likelihood that most people will experience, at one time or another, some of the symptoms of a bronchitic ailment. Such illnesses may occur either in the form of acute, usually periodic attacks or as chronic afflictions which often become progressively more serious over time.

Taylor, D.

Series on Health
March 1977

This study of the reorganised National Health Service is divided into two papers. The first describes the new structure and the management concepts on which it was based and the second examines the progress of and the criticisms made about the NHS since 1974. They were designed to complement one another although readers already familiar with the health service's administrative format may prefer to confine their attention to the latter study.

January 1977

Viral hepatitis consists of at least two distinct disease entities. Although they are both virus infections of the liver which may lead to clinical 'yellow jaundice', they are caused by different viruses and have contrasting aetiologies and epidemiologies.

Series on Health
October 1976

Asthma, a term derived from the Greek meaning to pant, was first clearly described by Aretaeus, a physician who practised in the second and third centuries of the Christian era. Many descriptions of the disorder appeared subsequently but they were often brief and inadequate and their value was limited still further by confused theories of causation and complicated methods of treatment (Major 1953).

September 1976

To present a balanced view of the brand name/generic controversy and the associated field of bioavailability. Many have discussed these problems; scientists, politicians, industrialists, legislators, hospital pharmacists, physicians, and clinical pharmacologists.

Series on Health
April 1976

Rabies, which is traditionally regarded as a mortal condition in humans once the symptoms have developed, is the best known and most feared of all the diseases which may be passed from animals to man. The course of the illness is usually extremely distressing, both physically and psychologically, although modem medicines can now help to relieve the suffering of its victims. Nevertheless there is still no effective cure. Awareness of this underlines the importance of preventive measures like immunisation and the control of rabies transmission amongst both wild and domestic animals.